Protective effect of cyclosporin A and FK506 from nitric oxide-dependent apoptosis in activated macrophages

British Journal of Pharmacology

Volumn 126, Issue 5, 1999, Pages 1139-1146

  Hortelano, Sonsoles ^a   López Collazo, Eduardo ^a   Boscá, Lisardo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Caspase 3; Cyclosporin A; Cytochrome c; FK506; Interferon ; Lipopolysaccharide; Macrophages; Nitric oxide

Indexed keywords

CASPASE 3; CYCLOSPORIN A; CYTOCHROME C; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN BAX; PROTEIN P53; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0344766073     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702422     Document Type: Article

References (42)

1. AGARWAL, M.L., TAYLOR, W.R., CHERNOV, M.V., CHERNOVA, O.B. & STARK, G.R. (1998). The p53 network. J. Biol. Chem., 273, 1-4.
2. ALBINA, J.E., CUI, S., MATEO, R.B. & REICHNER, J.S. (1993). Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol., 150, 5080-5085.
3. CALMELS, S., HAINAUT, P. & OHSHIMA, H. (1997). Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res., 57, 3365-3369.
4. CARROLL, M.C. & PRODEUS, A.P. (1998). Linkages of innate and adaptive immunity. Curr. Opin. Immunol., 10: 36-40.
5. CONDE, M., ANDRADE, J., BEDOYA, F.J., SANTA MARIA, C. & SOBRINO, F. (1995). Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect of nitric oxide synthase activity. Immunology, 84, 476-481.
6. DOHERTY, T.M. (1995). T-cell regulation of macrophage function. Curr. Opin. Immunol., 7, 400-404.
7. DUMONT, F.J., STARUCH, M.J., KOPRAK, S.L., SIEKIERKA, J.J., LIN, C.S., HARRISON, R., SEWELL, T., KINDT, V.M., BEATTIE, T.R. & WYVRATT, M. et al. (1992). The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med., 176, 751-760.
8. CENARO, A.M., HORTELANO, S., ALVAREZ, A., MARTINEZ-A.C. & BOSCA, L. (1995). Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest., 95, 1884-1890.
9. GREEN, D. & KROEMER, G. (1998). The central executioners of apoptosis: caspases or mitochondria. Trends. Cell Biol., 8, 267-271.
10. GREEN, D.R. & REED, J.C. (1998). Mitochondria and apoptosis. Science, 281, 1309-1312.
11. GREEN, S.J. & NACY, C.A. (1993). Antimicrobial and immunopathological effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis., 6, 384.
12. HATTORI, Y. & NAKANISHI, N. (1995). Effects of cyclosporin A and FK506 on nitric oxide and tetrahydrobiopterin sysnthesis in bacterial lipopolysaccharide-treated J774 macrophages. Cell Immunol., 165, 7-11.
13. HOBRUG, C.H.E., DE HASS, M., VOM DEM BORNE, A.E.G., VERHOVEN, A.J., REUTLINGSPERGER, C.P.M. & ROOS, D. (1995). Human neutrophils lose their surface FCγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood, 85, 532-540.
14. HORIGOME, A., HIRANO, T., OKA, K., TAKEUCHI, H., SAKURAI, E., KOZAKI, K., MATSUNO, N., NAGAO, T. & KOZAKI, M. (1997). Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells. Immunopharmacology, 37, 87-94.
15. HORTELANO, S. & BOSCÁ, L. (1997). 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes. Mol. Pharmacol., 51, 414-421.
16. HORTELANO, S., DALLAPORTA, B., ZAMZAMI, N., HIRSCH, T., SUSIN, S.A., MARZO, I., BOSCA, L. & KROEMER, O. (1997). Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett., 410, 373-377.
17. KROEMER, K. (1997). The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med., 3, 614-620.
18. LIEBERMANN, D.A., HOFFMAN, B. & STEINMAN, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene, II, 199-210.
19. LOTEM, J. & SACHS, L. (1995). Regulation of bcl-2, bcl-xL and bax in the control of apoptosis by hematopoietic cytokines and dexamethasone. Cell Growth Differ., 6, 647-653.
20. MACMICKING, J., XIE, Q.W. & NATHAN, C. (1997). Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350.
21. MARZO, I., BRENNER, C., ZAMZAMI, N., SUSIN, S.A., BEUTNRE, G., BRDICZKA, D., REMY, R., XIE, Z.H., REED, J.C. & KROEMER, G. (1998). The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins. J. Exp. Med., 187, 1261-1271.
22. MASON, J. (1990). Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals. Pharmacol. Rev., 41, 423-434.
23. MENGUAS, K., RIORDAN, F.A., HOFFBRAND, A.V. & WICKREMASINGHE, R.G. (1996). Co-ordinate downregulation of bcl-2 and bax expression during granulocyte and macrophage-like differentiation of the HL60 promyelocytic leukaemia cell line. FEBS Lett., 394, 356-360.
24. MESSMER, U.K. & BRUNNE, B. (1996). Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J., 319, 299-305.
25. MESSMER, U.K., REED, U.K. & BRUNE, B. (1996a). Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem., 271, 20192-20197.
26. MESSMER, U.K., REINER, D.M., REED, J.C. & BRUNE, B. (1996b). Nitric oxide induced poly(ADP-ribose) polymerase apoptosis is blocked by Bcl-2. FEBS Lett., 384, 162-166.
27. MITRY, R.R., SARRAF, C.E., WU, C.G., PIGNATELLI, M. & HABIB, N.A. (1997). Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression. Lab. Invest., 77, 369-378.
28. NATHAN, C. (1997). Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest., 100, 2417-2423.
29. NATHAN, C. & HIBBS, Jr J.B. (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Op. Immunol., 3, 65-70.
30. NATHAN, C. & XIE, Q.-W. (1994). Nitric oxice synthases: roles, tolls and controls. Cell, 78, 915-918.
31. OKADA, S., ZHANG, H., HATANO, M. & TOKUHISA, T. (1998). A physiological role of Bcl-xL induced in activated macrophages. J. Immunol., 160, 2590-2596.
32. QUEMENEUR, E., MOUTIEZ, M., CHARBONNIER, J.B. & MENEZ, A. (1998). Engineering cyclophilin into a proline-specific endopeptidase. Nature, 391, 301-304.
33. SCHREIBER, S.L. & CRABTREE, G.R. (1992). The mechanism of cyclosporin A and FK-506. Immunol. Today, 13, 136-142.
34. SHEVACH, E.M. (1985). The effects of cyclosporin A on the immune system. Annu. Rev. Immunol., 3, 397-427.
35. SIGNAL, N.H. & DUMONT, F.J. (1992). Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol., 10, 519-560.
36. TERENZI, F., DÍAZ-GUERRA, M.J.M., CASADO, M., HORTELANO, S., LEONI, S. & BOSCÁ, L. (1995). Bacterial lipopeptides induce nitric oxide synthase and promote apoptosis through nitric oxide-independent pathways in rat macrophages. J. Biol. Chem., 270, 6017-6021.
37. THORNBERRY, N.A. & LAZEBNIK, Y. (1998). Caspases: Enemies within. Science, 281, 1312-1316.
38. VANDER HEIDEN, M., CHANDEL, N.S., WILLIAMSON, E.K., SCHUMACKER, P.T., THOMPSON, C.B. (1997). Bcl-xl regulates the membrane potential and volume homeostasis of mitochondria. Cell, 91, 627-637.
39. VAN ROOIJEN, N., SANDERS, A. (1997). Elimination, blocking, and activation of macrophages: three of a kind? J. Leukoc. Biol., 62, 702-709.
40. VELASCO, M., DÍAZ-GUERRA, M.J.M., DÍAZ-ACHIRICA, P., ANDREU, D., RIVAS, L., BOSCÁ, L. (1997). Macrophage triggering with cecropin A and melittin-derived peptides induces type II nitric oxide synthase expression. J. Immunol., 197, 4437-4443.
41. WANG, M.S., ZELENY-POOLEY, M. & GOLD, B.G. (1997). Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther., 283, 1084-1093.
42. WARING, P. & BEAVER, J. (1996). Cyclosporin A rescues thymocytes from apoptosis induced by very low concentrations of thapsigargin: effects on mitochondrial function. Exp. Cell Res., 227, 264-276.